
Oncologist

No OPD information available
Hemophagocytic Lymphohistiocytosis
Non-Langerhans-Cell Histiocytosis
Arachnoiditis
Histiocytosis
Reticulohistiocytoma
X-Linked Lymphoproliferative Disease
Kevin T. Thia is a male healthcare provider who specializes in treating various conditions such as Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Arachnoiditis, Histiocytosis, Reticulohistiocytoma, and X-Linked Lymphoproliferative Disease.
Kevin T. Thia helps patients by using special skills and treatments to address their medical needs. He is known for his expertise in diagnosing and managing complex diseases, providing personalized care to each patient.
Patients trust Kevin T. Thia because he communicates effectively, listens to their concerns, and involves them in decision-making about their health. He creates a supportive and compassionate environment that puts patients at ease during their treatment.
Kevin T. Thia stays updated with the latest medical knowledge and research through continuous education, attending conferences, and collaborating with other healthcare professionals. This ensures that he provides the most advanced and effective treatments to his patients.
In his interactions with colleagues, Kevin T. Thia is known for his collaborative approach and willingness to work as a team to deliver the best possible care to patients. He values teamwork and mutual respect among medical professionals.
Kevin T. Thia's work has had a positive impact on many patients' lives by improving their health outcomes and quality of life. His dedication to providing high-quality care and his commitment to staying informed about advancements in medicine have benefited numerous individuals under his care.
One of Kevin T. Thia's notable publications is "Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma," published in the Journal for Immunotherapy of Cancer on August 27, 2024. This publication demonstrates his contribution to advancing medical knowledge and improving patient outcomes in the field of oncology.
